“The global dermatology drugs market is expected to grow from $66.8 billion in 2018 to $97.5 billion in 2022 at a CAGR of 9.9%” Dermatology Drugs Market Competitor Briefing 2019 – BCC Research
- Dermatology Drugs Market Competitor Briefing 2019
- Association of aortic vascular uptake of 18FDG by PET/CT and aortic wall thickness by MRI in psoriasis: a prospective observational study.
By: Groenendyk, Jacob W.; Shukla, Parag; Dey, Amit K.; Elnabawi, Youssef A.; Aksentijevich, Milena; Choi, Harry; Genovese, Leonard D.; Harrington, Charlotte L.; Natarajan, Balaji; Goyal, Aditya; Reddy, Aarthi S.; Rodante, Justin; Kabbany, Mohammad Tarek; Sadek, Ahmed; Al Najafi, Mina; Playford, Martin P.; Joshi, Aditya A.; Ahlman, Mark A.; Gelfand, Joel M.; Bluemke, David A. European Journal of Nuclear Medicine & Molecular Imaging. Nov2019, Vol. 46 Issue 12, p2488-2495. 8p. 1 Color Photograph, 3 Charts. DOI: 10.1007/s00259-019-04454-w. , Database: Business Source Corporate Plus
- Experience of Being Young With Psoriasis: Self-Management Support Needs.
By: Kragballe, Knud; Rasmussen, Gitte Susanne; Maindal, Helle Terkildsen; Lomborg, Kirsten. Qualitative Health Research. Jan2018, Vol. 28 Issue 1, p73-86. 14p. DOI: 10.1177/1049732317737311. , Database: Business Source Corporate Plus
- Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis.
By: Langley, Richard G.; Kasichayanula, Sree; Trivedi, Mona; Aras, Girish A.; Kaliyaperumal, Arunan; Yuraszeck, Theresa; Gibbs, John; Gibbs, Megan; Kricorian, Greg; Paller, Amy S. Journal of Clinical Pharmacology. Mar2018, Vol. 58 Issue 3, p340-346. 7p. DOI: 10.1002/jcph.1029. , Database: Business Source Corporate Plus
- Psoriasis biologics: a new era of choice.
By: Mahil, Satveer K; Smith, Catherine H. Lancet. Sep2019, Vol. 394 Issue 10201, p807-808. 2p. DOI: 10.1016/S0140-6736(19)31772-6. , Database: Business Source Corporate Plus
- How to disinfect foot trimming knives to reduce digital dermatitis.
By: Price, Rhian. Farmers Weekly. 9/6/2019, pN.PAG-N.PAG. 1p. , Database: Business Source Corporate Plus
- Dermatologicals Iraq
- OTC Iraq
- Consumer Health Iraq
- Dermatologicals Middle East and Africa
- Disruptive Innovations in Scalp Care (September 2019)
- Innovations in Biopharmaceutical Treatments (July 2018)
- Atopic dermatitis Phase II benchmarking outlook (October 2019)
- Comorbid conditions that complicate Atopic dermatitis (April 2019)
- Hanmi launches seborrheic dermatitis treatment (April 2019)
Enterprise Ireland clients can access Datamonitor Healthcare’s in-depth analysis of the Psoriasis and Atopic Dermatitis market. The report covers various aspects of the market including;
- Treatment of the Disease
- Marketed and Pipeline Drugs
- Forecast
- Epidemiology.
Clients can view the latest industry briefs and industry trend analyses of the diabetes market with Fitch Solutions. With the MedTrack database, clients can search research and development spending and view company details and financials.
Clients who wish to view the reports or have any queries can contact the Market Research Centre at market.research@enterprise-ireland.com. Clients can view the list of resources the Market Research Centre has available at this link.
Important note: All databases are subject to copyright which will be explained to clients on their visit. The use of cameras and USBs in the Centre is strictly prohibited.